In particular, in colon cancer, CCSCs have been identified in established colon cancer cell lines or in primary tumors through their expression of CD133, CD44, CD166, Lgr5, EpCAM, ALDH1 and β-catenin alone or through combinations of these markers [10–17]. Here, LGR5 is linked to malignant colon neoplasm.